Numerous investigations have demonstrated that CTLA-4 genetic polymorphisms may have association with human breast cancer susceptibility (Erfani et al., 2006; Ghaderi et al., 2004; Li et al., 2012; Li et al., 2008; Minhas et al., 2014; Sun et al., 2008; Wang et al., 2007; Zhifu et al., 2015; Kong, 2010). Here, CTLA4 is linked to breast carcinoma.